Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET

INTRODUCTION Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well-oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE) could therefore be used to adapt to patient-specific radioresistance governed by intrinsic radiosensitivity and hypoxia. METHODS A combined RBE and OER weighted dose (ROWD) calculation method was implemented in a FLUKA Monte Carlo (MC) based treatment planning tool. The method is based on the linear quadratic model, with α and β parameters as a function of the OER, and therefore a function of the linear energy transfer (LET) and partial oxygen pressure (pO2 ). Proton therapy plans for two head and neck cancer (HNC) patients were optimized with pO2 estimated from [18 F]-EF5 positron emission tomography (PET) images. For the ROWD calculations, an RBE of 1.1 (RBE1.1,OER ) and two variable RBE models, Rørvik (ROR) and McNamara (MCN), were used, alongside a reference plan without incorporation of OER (RBE1.1 ). RESULTS For the HNC patients, treatment plans in line with the prescription dose and with acceptable target ROWD could be generated with the established tool. The physical dose was the main factor modulated in the ROWD. The impact of incorporating OER during optimization of HNC patients was demonstrated by the substantial difference found between ROWD and physical dose in the hypoxic tumor region. The largest physical dose differences between the ROWD optimized plans and the reference plan was 12.2 Gy. CONCLUSION The FLUKA MC based tool was able to optimize proton treatment plans taking the tumor pO2 distribution from hypoxia PET images into account. Independent of RBE-model, both elevated LET and physical dose were found in the hypoxic regions, which shows the potential to increase the tumor control compared to a conventional optimization approach.

[1]  A. Lomax,et al.  Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer , 2021, Radiation oncology.

[2]  B. S. Sørensen,et al.  Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  J. Debus,et al.  Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions , 2021, Advances in radiation oncology.

[4]  H. Minn,et al.  The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors. , 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[5]  L. Marcu,et al.  Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[6]  M. Durante,et al.  Kill painting of hypoxic tumors with multiple ion beams , 2019, Physics in medicine and biology.

[7]  Lars Fredrik Fjæra,et al.  Exploration and application of phenomenological RBE models for proton therapy , 2018, Physics in medicine and biology.

[8]  H. P. Kok,et al.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies , 2018, Radiation oncology.

[9]  H. Minn,et al.  Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  M. Alber,et al.  Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Michael Scholz,et al.  Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model , 2017, Physics in medicine and biology.

[12]  T. Inaniwa,et al.  Adaptation of the microdosimetric kinetic model to hypoxia , 2016, Physics in medicine and biology.

[13]  M. Durante,et al.  Kill-painting of hypoxic tumours in charged particle therapy , 2015, Scientific Reports.

[14]  Aimee L. McNamara,et al.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data , 2015, Physics in medicine and biology.

[15]  F J Gilbert,et al.  Imaging tumour hypoxia with positron emission tomography , 2014, British Journal of Cancer.

[16]  I. Toma-Dasu,et al.  Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes , 2014, Journal of radiation research.

[17]  S. McKeown,et al.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. , 2014, The British journal of radiology.

[18]  K. Parodi,et al.  A Monte Carlo-based treatment-planning tool for ion beam therapy , 2013, Journal of radiation research.

[19]  M Durante,et al.  Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification , 2013, Physics in medicine and biology.

[20]  K Parodi,et al.  A Monte Carlo-based treatment planning tool for proton therapy , 2013, Physics in medicine and biology.

[21]  T. Sakae,et al.  Microdosimetric calculation of relative biological effectiveness for design of therapeutic proton beams† , 2012, Journal of radiation research.

[22]  R. Jeraj,et al.  Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling. , 2011, Nuclear medicine and biology.

[23]  Jan J Wilkens,et al.  Modelling of the oxygen enhancement ratio for ion beam radiation therapy , 2011, Physics in medicine and biology.

[24]  Joseph O Deasy,et al.  Radiotherapy dose-volume effects on salivary gland function. , 2010, International journal of radiation oncology, biology, physics.

[25]  O Jäkel,et al.  Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. , 2000, Physics in medicine and biology.

[26]  M Scholz,et al.  Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. , 2000, Physics in medicine and biology.

[27]  TIKVAH ALPER,et al.  Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. , 1956, Nature.

[28]  R. Chirla,et al.  PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer. , 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.